Drug Interaction Between Tacrolimus and Carbamazepine in a Japanese Heart Transplant Recipient: A Case Report

Journal of Heart and Lung Transplantation

Volumn 28, Issue 4, 2009, Pages 409-411

  Wada, Kyoichi ^a   Takada, Mitsutaka ^b   Sakai, Mika ^a   Ochi, Hiroyuki ^a   Kotake, Takeshi ^a   Okada, Hiroshi ^a   Morishita, Hideki ^a   Oda, Noboru ^a   Mano, Akiko ^a   Kato, Tomoko S ^a   Komamura, Kazuo ^c   Nakatani, Takeshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; VALPROIC ACID; ZONISAMIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPILEPSY; FEMALE; HEART TRANSPLANTATION; HUMAN; JAPAN; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CARDIOMYOPATHY, DILATED; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 62949237271     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.01.009     Document Type: Article

References (11)

1. Kino T., Hatanaka H., Miyata S., Inamura N., et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 40 (1987) 1256-1265
2. Ochiai T., Nakajima K., Nagata M., Hori S., Asano T., and Isono K. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44 (1987) 734-738
3. Lamba J.K., Lin Y.S., Schuetz E.G., and Thummel K.E. Genetic contribution to variable human CYP3A-mediated metabolism. Adv Drug Deliv Rev 54 (2002) 1271-1294
4. Fireman M., DiMartini A.F., Armstrong S.C., and Cozza K.L. Immunosuppressants. Psychosomatics 45 (2004) 354-360
5. Shitrit D., Ollech J.E., Ollech A., et al. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction. J Heart Lung Transplant 24 (2005) 2148-2152
6. Boussaud V., Daudet N., Billaud E.M., et al. Neuromuscular painful disorders: a rare side effect of voriconazole in lung transplant patients under tacrolimus. J Heart Lung Transplant 27 (2008) 229-232
7. Wada K., Takada M., Ueda T., et al. Drug interactions between tacrolimus and phenytoin in Japanese heart transplant recipients: 2 case reports. Int J Clin Pharmacol Ther 45 (2007) 524-528
8. Patsalos P.N., Fröscher W., Pisani F., and van Rijn C.M. The importance of drug interactions in epilepsy therapy. Epilepsia 43 (2002) 365-385
9. Cooney G.F., Mochon M., Kaiser B., Dunn S.P., and Goldsmith B. Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients. Pharmacotherapy 15 (1995) 353-356
10. Hillebrand G., Castro L.A., van Scheidt W., Beukelmann D., Land W., and Schmidt D. Valproate for epilepsy in renal transplant recipients receiving cyclosporine. Transplantation 43 (1987) 915-916
11. Rösche J., Fröscher W., Abendroth D., and Liebel J. Possible oxcarbazepine interaction with cyclosporine serum levels: a single case study. Clin Neuropharmacol 24 (2001) 113-116